The rollout of the mpox vaccine in the Democratic Republic of Congo (DRC) has been slower than anticipated, raising concerns about the country’s ability to curb the spread of the virus.
A senior health official, speaking on condition of anonymity to reporters, cited logistical challenges as the primary reason for the delays. These include inadequate cold chain systems, difficulties in reaching remote regions, and a limited supply of vaccines from global partners.
Reporters making their way to North Kivu province of DRC found that locals seemed unaware or suspicious of the shots.
The World Health Organization (WHO) had partnered with DRC’s Ministry of Health to accelerate the vaccine campaign, especially after a surge in mpox cases in 2023. However, supply chain disruptions and funding shortfalls have hindered these efforts. While urban areas like Kinshasa have seen some progress, rural regions, where outbreaks have been more severe, are struggling to access the vaccines.
Health experts are concerned that the delay could prolong the outbreak, with vulnerable populations at greater risk. WHO officials are urging international donors to expedite aid to ensure that vaccines reach those in need.
The DRC has experienced periodic outbreaks of mpox, a viral zoonotic disease, and is one of the African countries hardest hit by the virus, making timely vaccination critical in controlling its spread.
